Patent Assignment from Basi, Guriq; Saldanha, Jose; and Yednock, Ted to Elan Pharmaceuticals, Inc.

United States Patent and Trademark Office, Patent Assignment 21127/669:
Corrective Assignment To Correct The First Name Of Assignor Number 1, To Guriq Basi And The Address Of Assignee To South San Francisco. Previously Recorded On Reel 012969 Frame 0848. Assignor(s) Hereby Confirms The Assignment Of Assignors Interest..

Assignors		Assignee
Basi, Guriq Paperwork Executed April 10, 2002 Saldanha, Jose Paperwork Executed March 7, 2002 Yednock, Ted Paperwork Executed April 10, 2002	Recorded June 21, 2008	Elan Pharmaceuticals, Inc. Elan Pharmaceuticals, Inc. 800 Gateway Boulevard South San Francisco, CA 94080-7085
Patents		Correspondent
Humanized Antibodies That Recognize Beta Amyloid Peptide X0Patent Application No. 10010942, Filed December 6, 2001 A1Application Publication No. 20030165496, Issued September 4, 2003 Humanized Antibodies That Recognize Beta Amyloid Peptide B2Utility Patent No. 7189819, Issued March 13, 2007		Rosemarie L. Celli Phone: +1 650 838 2000

Updated June 23, 2008

View this assignment via USPTO Assignments on the Web

Statistics

This assignment has been viewed 3 times.

Issues Laws Cases News Firms Entities Pro

AI text generation	None
AI document summarization	None
AI-augmented search	None
AI-generated images	None
AI chat or Q&A interface	Linkable via MCP
Third party AI contribution in government documents	Possible